Hypertension: physiology and pathophysiology (Q38110492)

29 August 2017

title

Hypertension: physiology and pathophysiology (English)

1 reference

29 August 2017

main subject

arterial hypertension

0 references

1 reference

2

Joey P Granger

1 reference

29 August 2017

John E Hall

1

1 reference

29 August 2017

Jussara M do Carmo

3

1 reference

29 August 2017

Alexandre A da Silva

4

1 reference

29 August 2017

John Dubinion

5

1 reference

29 August 2017

Eric George

6

1 reference

29 August 2017

Shereen Hamza

7

1 reference

29 August 2017

Joshua Speed

8

1 reference

29 August 2017

Michael E Hall

9

1 reference

29 August 2017

publication date

1 October 2012

1 reference

29 August 2017

published in

Comprehensive Physiology

1 reference

29 August 2017

volume

2

1 reference

29 August 2017

issue

4

1 reference

29 August 2017

page(s)

2393-2442

1 reference

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Deletion of Endothelial Cell Endothelin B Receptors Does Not Affect Blood Pressure or Sensitivity to Salt

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Divergent results using clinic and ambulatory blood pressures: report of a darusentan-resistant hypertension trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Nitric oxide deficiency in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Antihypertensive Effect of Prolonged Blockade of Angiotensin Formation in Benign and Malignant, one- and two-Kidney Goldblatt Hypertensive Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Effect in the conscious dog of constriction of the renal artery to a sole remaining kidney on haemodynamics, sodium balance, body fluid volumes, plasma renin concentration and pressor responsiveness to angiotensin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Mineralocorticoids in congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

AT1-receptor antagonism reverses the blood pressure elevation associated with diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Is there an unrecognized epidemic of primary aldosteronism? Pro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Hyperaldosteronism among black and white subjects with resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Salt sensitivity in hypertension. Renal and cardiovascular implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Role of nitric oxide deficiency in the development of hypertension in hydronephrotic animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Chronic cardiovascular and renal actions of leptin: role of adrenergic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Essential Hypertension : Part I: Definition and Etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

L-arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Cyclooxygenases, the kidney, and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

The role of insulin receptor substrate 2 in hypothalamic and beta cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Renal Sinus Fat and Poor Blood Pressure Control in Middle-Aged and Elderly Individuals at Risk for Cardiovascular Events

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Placental cytokines and the pathogenesis of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Changes in renal vascular sensitivity and arterial pressure associated with sodium intake during long-term intrarenal norepinephrine infusion in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Role of renal NO production in the regulation of medullary blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Lymphocyte responses exacerbate angiotensin II-dependent hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

The role of the sympathetic nervous system in obesity-related hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Role of hypothalamic melanocortin 3/4-receptors in mediating chronic cardiovascular, renal, and metabolic actions of leptin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Long-term regulation of arterial blood pressure by hypothalamic nuclei: some critical questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Obesity and hypertension: two epidemics or one?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Neural control of the kidney: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Translational medicine: the antihypertensive effect of renal denervation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Measurement of reactive oxygen species in cardiovascular studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Control of Blood Pressure, Appetite, and Glucose by Leptin in Mice Lacking Leptin Receptors in Proopiomelanocortin Neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Inflammation and restenosis: implications for therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Sex hormones and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

The sympathetic system and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Mechanisms of sympathetic activation in obesity-related hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Vascular endothelial growth factor receptor 2 controls blood pressure by regulating nitric oxide synthase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Losartan metabolite EXP3179 blocks NADPH oxidase-mediated superoxide production by inhibiting protein kinase C: potential clinical implications in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Mineralocorticoid receptors, salt-sensitive hypertension, and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Mechanisms of mineralocorticoid action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Reconsidering the roles of the mineralocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabetes, infertility, and thermal dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Null mutation of endothelin receptor type B gene in spotting lethal rats causes aganglionic megacolon and white coat color

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Salt-sensitive hypertension in endothelin-B receptor-deficient rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Monogenic forms of low-renin hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

The role of reactive oxygen species in the regulation of tubular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Combined knockout of collecting duct endothelin A and B receptors causes hypertension and sodium retention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

STUDIES ON EXPERIMENTAL HYPERTENSION : I. THE PRODUCTION OF PERSISTENT ELEVATION OF SYSTOLIC BLOOD PRESSURE BY MEANS OF RENAL ISCHEMIA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Diagnosis and localization of pheochromocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Vascular endothelial growth factor inhibitors and hypertension: a central role for the kidney and endothelial factors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Endothelin, the kidney, and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Abnormal pressure-natriuresis in hypertension: role of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: results of the CROSS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Modulation of blood pressure by central melanocortinergic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Renoprotection by ACE inhibition or aldosterone blockade is blood pressure-dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

The sympathetic control of blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

The surprising kidney-fluid mechanism for pressure control--its infinite gain!

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Circulation: overall regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

The kidney, hypertension, and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Mechanisms of hypertension and kidney disease in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Insulin resistance, hyperinsulinemia, and hypertension: causes, consequences, or merely correlations?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Cardiovascular actions of insulin: are they important in long-term blood pressure regulation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Hemodynamic and renal responses to chronic hyperinsulinemia in obese, insulin-resistant dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Mechanisms of obesity-associated cardiovascular and renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Is obesity a major cause of chronic kidney disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Obesity hypertension: role of leptin and sympathetic nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Resistance to metabolic actions of insulin and its role in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic heterogeneity of Liddle syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Is hypertension an immunologic disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Inflammation, immunity, and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Migration, blood pressure pattern, and hypertension: the Yi Migrant Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Body mass index and risk for end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Subtle renal injury is likely a common mechanism for salt-sensitive essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

The effect of weight loss intervention on antihypertensive medication requirements in the hypertension Optimal Treatment (HOT) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Endothelin-A Receptor Antagonism Attenuates the Hypertension and Renal Injury in Dahl Salt-Sensitive Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

The renal medullary endothelin system in control of sodium and water excretion and systemic blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Device-based antihypertensive therapy: therapeutic modulation of the autonomic nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Genome-wide association studies will unlock the genetic basis of hypertension.: con side of the argument

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Transcription-modulating drugs: a new frontier in the treatment of essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

20-HETE and furosemide-induced natriuresis in salt-sensitive essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Differential regulation of natriuresis by 20-hydroxyeicosatetraenoic Acid in human salt-sensitive versus salt-resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: effect of tumor necrosis factor-alpha blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Pathophysiology of hypertension in response to placental ischemia during pregnancy: a central role for endothelin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Feast or famine: the sympathetic nervous system response to nutrient intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Nephron heterogeneity: clue to the pathogenesis of essential hypertension and effectiveness of angiotensin-converting enzyme inhibitor treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

NADPH oxidases: functions and pathologies in the vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Hysterectomy, Oophorectomy, and Endogenous Sex Hormone Levels in Older Women: The Rancho Bernardo Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Global burden of blood-pressure-related disease, 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Genome-wide association study of blood pressure and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Molecular genetics of human blood pressure variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Molecular mechanisms of human hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Interpreting abnormal proteinuria in pregnancy: the need for a more pathophysiological approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Recent insights into the interactions between the baroreflex and the kidneys in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Chronic lowering of blood pressure by carotid baroreflex activation: mechanisms and potential for hypertension therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Environmental and genetic sources of familial aggregation of blood pressure in Tecumseh, Michigan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Molecular genetics of human hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Mendelian forms of human hypertension and mechanisms of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Geneticism of essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

A review of the role of atrial natriuretic peptide gene polymorphisms in hypertension and its sequelae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Roles for VEGF in the adult.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

An overview of pheochromocytoma: history, current concepts, vagaries, and diagnostic challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Renal and vascular oxidative stress and salt-sensitivity of arterial pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

The WNKs: atypical protein kinases with pleiotropic actions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Mechanisms mediating renal sympathetic activation to leptin in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Recent advances in understanding leptin signaling and leptin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Human hypertension caused by mutations in the kidney isozyme of 11β–hydroxysteroid dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Molecular and anatomical determinants of central leptin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Role of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Role of renal interstitial pressure as a mediator of sodium retention during systemic blockade of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Darusentan: an effective endothelinA receptor antagonist for treatment of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Genome-wide association study identifies eight loci associated with blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Salt handling and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Prevalence of overweight and obesity in the United States, 1999-2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Reduced endothelial NO-cGMP-mediated vascular relaxation and hypertension in IL-6-infused pregnant rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Role of nitric oxide in the regulation of nephron transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin,

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Body fat distribution and cardiovascular disease risk factors in pre- and postmenopausal obese women with similar BMI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Chronic antioxidant therapy fails to ameliorate hypertension: potential mechanisms behind

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

The burden of blood pressure-related disease: a neglected priority for global health

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Genetic silencing of Nox2 and Nox4 reveals differential roles of these NADPH oxidase homologues in the vasopressor and dipsogenic effects of brain angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Endothelin as a clinical target in the treatment of systemic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Obesity-associated hypertension: new insights into mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Novel mechanisms responsible for postmenopausal hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Role of oxidative stress in angiotensin-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Lisinopril versus hydrochlorothiazide in obese hypertensive patients: a multicenter placebo-controlled trial. Treatment in Obese Patients With Hypertension (TROPHY) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Effects of captopril on sympathetic activity, lipid and carbohydrate metabolism in a model of obesity-induced hypertension in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

P-450 metabolites of arachidonic acid in the control of cardiovascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

State-of-the-Art lecture. Role of angiotensin and oxidative stress in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Interactions between obesity and obstructive sleep apnea: implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Salt intake, endothelial cell signaling, and progression of kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Vascular endothelin in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Role of reactive oxygen species in endothelin-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Chronic Leptin Infusion Increases Arterial Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Sexual differences in the control of energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Adaptation to increased dietary salt intake in the rat. Role of endogenous nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Nitric oxide influences blood flow distribution in renovascular hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Intra-abdominal pressure, sagittal abdominal diameter and obesity comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Reactive oxygen species in the vasculature: molecular and cellular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Atrial natriuretic peptides in pathophysiological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Autonomic regulation of blood pressure in menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Salt sensitivity of blood pressure in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Ethnic differences in insulinemia and sympathetic tone as links between obesity and blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Epidemiology of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Cushing, cortisol, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Reactive oxygen species: roles in blood pressure and kidney function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Human hypertension caused by mutations in WNK kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Antihypertensive effect of alpha- and beta-adrenergic blockade in obese and lean hypertensive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Obesity, Sleep Apnea, and Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Epidemiologic and economic consequences of the global epidemics of obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Leptin signaling and obesity: cardiovascular consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Minireview: Primary Aldosteronism—Changing Concepts in Diagnosis and Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Adult hypertension and kidney disease: the role of fetal programming.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Effects of pioglitazone on calcium channels in vascular smooth muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

Overweight and sympathetic overactivity in black Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Aldosterone: villain or protector?

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Tumor necrosis factor-alpha-induced hypertension in pregnant rats results in decreased renal neuronal nitric oxide synthase expression

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Endothelin type a receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Hypertension in obese Zucker rats. Role of angiotensin II and adrenergic activity

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Increased renal Na-K-ATPase, NCC, and beta-ENaC abundance in obese Zucker rats

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Blood pressure and inflammation in apparently healthy men

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Long-term control of arterial blood pressure

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Genes and family environment explain correlations between blood pressure and body mass index

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Glucocorticoid-remediable aldosteronism (GRA): diagnosis, variability of phenotype and regulation of potassium homeostasis

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Some observations on the quantitative anatomy of the kidney

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Renal proliferative and phenotypic changes in rats with two-kidney, one-clip Goldblatt hypertension

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Response of hypertension to conventional antihypertensive treatment and/or steroidogenesis inhibitors in Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Renovascular hypertension and ischemic nephropathy

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Incidence and precursors of hypertension in young adults: the Framingham Offspring Study

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Angiotensin-sodium interaction in blood pressure maintenance of renal hypertensive and normotensive rats

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Collecting duct-specific knockout of the endothelin B receptor causes hypertension and sodium retention

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Role of renal nerves in mediating the hypertensive effects of nitric oxide synthesis inhibition

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

https://api.crossref.org/works/10.1002/CPHY.C110058

1 reference

7 January 2021

Long-term hypotensive and renal effects of atrial natriuretic peptide

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Sympathetic activation in obese normotensive subjects

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Obesity-induced hypertension. Renal function and systemic hemodynamics

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Role of renal hemodynamics and arterial pressure in aldosterone "escape"

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Pressure natriuresis and control of arterial pressure during chronic norepinephrine infusion.

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Long-term administration of L-arginine improves nitric oxide release from kidney in deoxycorticosterone acetate-salt hypertensive rats

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Body mass index and blood pressure in Korean men and women: the Korean National Blood Pressure Survey

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

The hemodynamic link between insulin resistance and hypertension

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Renal denervation attenuates the sodium retention and hypertension associated with obesity

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Role of endothelin in mediating the attenuated renal hemodynamics in Dahl salt-sensitive hypertension

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Inhibition of NO synthesis enhances chronic cardiovascular and renal actions of leptin

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Angiotensin II hypertension is attenuated in interleukin-6 knockout mice

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

The loss of endothelium-dependent vascular relaxation in hypertension

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Prolonged activation of the baroreflex abolishes obesity-induced hypertension

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Nitric oxide regulates renal hemodynamics and urinary sodium excretion in dogs

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in experimental hypertension

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

ANP in regulation of arterial pressure and fluid-electrolyte balance: lessons from genetic mouse models

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Renal morphological changes after sinoaortic denervation in dogs

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

L-arginine administration normalizes pressure natriuresis in hypertensive Dahl rats

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Evidence for endothelin involvement in the response to high salt

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Patients with insulinoma show insulin resistance in the absence of arterial hypertension

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

The metabolic syndrome: is this diagnosis necessary?

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Neural mechanisms in human obesity-related hypertension

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Nitric oxide, the kidney and hypertension

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Increased contents of phospholipids, cholesterol, and lipid peroxides in decidua basalis in women with preeclampsia

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Familial hyperaldosteronism type II: five families with a new variety of primary aldosteronism

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Melanocortin-4 receptor mediates chronic cardiovascular and metabolic actions of leptin

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Response of chronic renovascular hypertension to surgical correction or prolonged blockade of the renin-angiotensin system by two inhibitors in the rat

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Salt sensitivity, pulse pressure, and death in normal and hypertensive humans

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

AUTOIMMUNE FACTORS ASSOCIATED WITH INFARCTION OF THE KIDNEY

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Effects of chronic baroreceptor stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Postmenopausal Hypertension

1 reference

https://api.crossref.org/works/10.1002/CPHY.C110058

7 January 2021

Identifiers

DOI

10.1002/CPHY.C110058

1 reference

29 August 2017

1 reference